Start
Features
Free trial / FAQ

Researchers
Physicians
Pharmacists
Ecotrophologists
Product Managers
in Health Industries

Loading…

Medical Research Finder

Legal Notice
Privacy
Terms of Use

meRfi® Microbiome - The Digital Gut Microbiome Reference (incl. AI Chat)
Prebiotics, Probiotics, FMT / Manipulators of the Intestinal Microbiota

AuthorsReferences (Sources)

meRfi® AI Chat

Cell cycle inhibitors (CCIs) & Acute myeloid leukemia (AML)

Welcome to meRfi Microbiome!

Please register to continue your trial period!

meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.

Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.

Start your free trial and transform your understanding of the gut microbiota today!

(Login)

Navigation

Cell cycle inhibitors (CCIs) are a new class of drugs in development for the treatment of Acute myeloid leukemia (AML). Specific drug targets being investigated include Cyclin D kinase, Aurora kinase, CHK1, and WEE1.
The development of optimal combinations is one of the greatest clinical challenges that must be overcome before these agents become AML therapies
Jammal et al. 2020 Expert Opinion on Emerging Drugs 25: 491-499

see also:
[Acute myeloid leukemia (AML) & Drugs/Treatments](brain://b1Do_aCZNEmvLEHvkSukYQ/AcuteMyeloidLeukemiaAml…

References (Sources)

Cell cycle inhibitors for the treatment of acute myeloid leukemia: a review of phase 2 & 3 clinical trials
Jammal et al. 2020 Expert Opinion on Emerging Drugs 25: 491-499
Review

AI Chat

7/1/2026

Chat with our artificial intelligence:

Start chat!

Cell cycle inhibitors (CCIs) & Acute myeloid leukemia (AML)

Welcome to meRfi Microbiome!

Navigation

Contents

References (Sources)

AI Chat